Your browser doesn't support javascript.
loading
Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.
Kimura, Takeshi; Uda, Atsushi; Sakaue, Tomoyuki; Yamashita, Kazuhiko; Nishioka, Tatsuya; Nishimura, Sho; Ebisawa, Kei; Nagata, Manabu; Ohji, Goh; Nakamura, Tatsuya; Koike, Chihiro; Kusuki, Mari; Ioroi, Takeshi; Mukai, Akira; Abe, Yasuhisa; Yoshida, Hiroyuki; Hirai, Midori; Arakawa, Soichi; Yano, Ikuko; Iwata, Kentaro; Tokimatsu, Issei.
Afiliação
  • Kimura T; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. kimutake@med.kobe-u.ac.jp.
  • Uda A; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan. kimutake@med.kobe-u.ac.jp.
  • Sakaue T; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Yamashita K; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Nishioka T; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Nishimura S; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Ebisawa K; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Nagata M; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Ohji G; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Nakamura T; Department of Infectious Disease, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Koike C; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Kusuki M; Department of Infectious Disease, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Ioroi T; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Mukai A; Department of Infectious Disease, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Abe Y; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Yoshida H; Department of Infectious Disease, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Hirai M; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Arakawa S; Department of Clinical Laboratory, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Yano I; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Iwata K; Department of Infection Control and Prevention, Kobe University Hospital, Kobe, Hyogo, Japan.
  • Tokimatsu I; Department of Clinical Laboratory, Kobe University Hospital, Kobe, Hyogo, Japan.
Infection ; 46(2): 215-224, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29134582
ABSTRACT

OBJECTIVE:

To evaluate the long-term effects of comprehensive antibiotic stewardship programs (ASPs) on antibiotic use, antimicrobial-resistant bacteria, and clinical outcomes.

DESIGN:

Before-after study.

SETTING:

National university hospital with 934 beds. INTERVENTION Implementation in March 2010 of a comprehensive ASPs including, among other strategies, weekly prospective audit and feedback with multidisciplinary collaboration.

METHODS:

The primary outcome was the use of antipseudomonal antibiotics as measured by the monthly mean days of therapy per 1000 patient days each year. Secondary outcomes included overall antibiotic use and that of each antibiotic class, susceptibility of Pseudomonas aeruginosa, the proportion of patients isolated methicillin-resistant Staphylococcus aureus (MRSA) among all patients isolated S. aureus, the incidence of MRSA, and the 30-day mortality attributable to bacteremia.

RESULTS:

The mean monthly use of antipseudomonal antibiotics significantly decreased in 2011 and after as compared with 2009. Susceptibility to levofloxacin was significantly increased from 2009 to 2016 (P = 0.01 for trend). Its susceptibility to other antibiotics remained over 84% and did not change significantly during the study period. The proportion of patients isolated MRSA and the incidence of MRSA decreased significantly from 2009 to 2016 (P < 0.001 and = 0.02 for trend, respectively). There were no significant changes in the 30-day mortality attributable to bacteremia during the study period (P = 0.57 for trend).

CONCLUSION:

The comprehensive ASPs had long-term efficacy for reducing the use of the targeted broad-spectrum antibiotics, maintaining the antibiotic susceptibility of P. aeruginosa, and decreasing the prevalence of MRSA, without adversely affecting clinical outcome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Gestão de Antimicrobianos Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Infection Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Gestão de Antimicrobianos Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Infection Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão